Client Alert: SyCipLaw secures 1st merger clearance from PCC: Acquisition by Sanofi of the CHC Business of Boehringer Ingelheim

The Philippine Competition Commission (PCC) has issued its first merger clearance under the implementing rules and regulations of the Philippine Competition Act. The clearance was for the proposed acquisition by Sanofi of the CHC business of Boehringer Ingelham. SyCipLaw acted as Philippine antitrust counsel to Sanofi.

Download the Client Alert for more information on the first merger clearance of PCC under the Philippine Competition Act.

This alert was authored by SyCipLaw partners Rose Marie M. King-Dominguez, Arlene M. Maneja, and Franco Aristotle G. Larcina.